We use cookies so we can provide you with the best online experience. By continuing to browse this site you are agreeing to our use of cookies. Click on the banner to find out more. Accept and close
BIBA Medical Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News Neuro News CX Symposium ilegx BIBA MedTech Insights
login
  Password reminder

RegisterEdit your account | View your account

Interventional News

The website for interventionalists

Contact us 

Follow us on twitter Find us on facebook
 




Featured Highlights
21 - 30 of 111   Items
FDA clears FlightPlan for Liver imaging tool for liver embolization procedures

FDA clears FlightPlan for Liver imaging tool for liver embolization procedures

Monday, 26 Nov 2012
The FlightPlan for Liver tool (GE Healthcare), developed by physicians and engineers, helps interventionalists plan their liver embolization procedures in a simpler manner. read more
CyberKnife VSI System now in India

CyberKnife VSI System now in India

Thursday, 22 Nov 2012
Accuray Incorporated has announced that Medanta – The Medicity Cancer Institute, and the Roentgen-BLK Super Speciality Hospital both recently acquired and started treating patients with the CyberKnife VSI System, marking it the first-in-country CyberKnife VSI System in India. read more
Thermedical receives FDA 510(k) clearance for new ablation system

Thermedical receives FDA 510(k) clearance for new ablation system

Wednesday, 07 Nov 2012
The new system, sponsored by the Massachussets Life Sciences Centre, utilises radiofrequency for the treatment of large tumours, including liver cancer. read more
Delcath receives regulatory approval for the Generation Two Hepatic Chemosat Delivery system in Australia

Delcath receives regulatory approval for the Generation Two Hepatic Chemosat Delivery system in Australia

Tuesday, 06 Nov 2012
The approval allows Delcath to market and sell the system used to treat unresectable metastatic melanoma in the liver in Australia. read more
Sirtex Medical launches SIR-Spheres microspheres in Latin America

Sirtex Medical launches SIR-Spheres microspheres in Latin America

Monday, 15 Oct 2012
The first treatment with the SIR-Spheres Microspheres for inoperable liver tumours was carried out at Hospital Italiano de Buenos Aires in Argentina. read more

FDA clears Surefire Medical Angiographic Catheters

Monday, 15 Oct 2012
According to a company release, the Surefire Angiographic Catheters are designed to provide interventional radiologists with greater flexibility and a high level of trackability when performing infusion procedures. read more

Philips and Biocompatibles team-up to advance image guided transarterial embolizations in interventional oncology

Wednesday, 19 Sep 2012
At CIRSE 2012, Philips and Biocompatibles announced a collaboration to advance the use of image guidance to control the delivery of beads during the arterial embolization of hypervascularised tumours. read more
Is there a difference in radioembolization outcomes between glass and resin microspheres?

Is there a difference in radioembolization outcomes between glass and resin microspheres?

Thursday, 06 Sep 2012
Is one device more effective than the other, with respect to radioembolization for hepatocellular carcinoma with or without portal vein thrombosis, metastatic colorectal cancer and neuroendocrine tumours? Examining the medical literature, the answer is “no”, Robert Lewandowski, Chicago, USA, said. read more
Surefire Infusion System for embolization procedures receives CE mark approval

Surefire Infusion System for embolization procedures receives CE mark approval

Wednesday, 05 Sep 2012
In a retrospective study of 29 patients, infusion of therapeutic agent with the Surefire Infusion System showed no angiographic evidence of reflux and no clinical evidence of non-target embolization. read more

UK’s NICE publishes guidance for ultrasound testing to diagnose liver cancer

Thursday, 30 Aug 2012
The guidance recommends the use of SonoVue (Bracco) in adults to investigate lesions to the liver that is detected incidentally, but not characterised, on an unenhanced ultrasound scan. read more
Found: 111   Displaying: 21-30
Results: 1 2 3 4 5 Next Go to:
Related Section
Clinical Trials
Interventional Oncology News
Interventional Oncology Supplement
Key Opinion Leaders discuss the role of Biocompatible's DC Bead at CIRSE and ILCA
IR Views
Literature
Oncology Useful Links

Related Feeds

Latest News





Features





Profiles





BIBA Medical, 44 Burlington Road, Fulham, London, SW6 4NX.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions